The decisions come five long years after the European Commission designated CBD products as novel foods. This FSA Scientific Committee endorsement indicates that the companies successfully met the rigorous safety criteria necessary to progress to the final stage of the Novel Food Licensing process.
Both authorizations are at a level of 10 mg for use in supplement, beverage, and confectionary for adults for Cannaray Brands (98% Isolate) and food supplements only for Chanelle McCoy (98% Synthetic), following a provisional Acceptable Daily Intake (ADI) of 10 mg/day. “We’re thrilled to share that Cannaray CBD’s journey in the novel food application process has taken a significant leap forward,” the brand announced on its LinkedIn.
“This advancement to the risk management stage is a testament to Cannaray’s unwavering dedication to excellence and compliance,” said Cannaray Brands MD Howard Radcliffe. “We are proud to be at the forefront of driving innovation and establishing best practices within the UK CBD industry.”
Ever since the EC updated its Novel Foods catalog to include CBD, companies in this space have been unable to bring new CBD products to market, and legality has remained uncertain for brands, suppliers, customers, retailers, and investors.
Shomi Malik, commercial and strategy lead at the premium white label CBD supplement supplier B3 Labs, commented on the update on LinkedIn: “Does this mean more authorizations are on the horizon? Massive news for the industry, after a seemingly never-ending saga.”
Chanelle McCoy, CEO of Chanelle McCoy Health, the brand owner of the lab-made pure CBD brand Pureis, said of the assessment: “This is a monumental achievement and a complete game-changer for the CBD industry.” With this milestone, McCoy said the company is poised to expand its product portfolio, incorporating CBD and other active ingredients into new Orals and Topicals.
“This strategic expansion aims to help the consumer navigate the product they choose for their particular needs,” she said. “These expansion plans not only signify diversification of the Pureis product range but also offer the potential of new job opportunities and economic growth within the UK.”
